DE60212861D1 - Verfahren zur Diagnose von Fettsucht - Google Patents

Verfahren zur Diagnose von Fettsucht

Info

Publication number
DE60212861D1
DE60212861D1 DE60212861T DE60212861T DE60212861D1 DE 60212861 D1 DE60212861 D1 DE 60212861D1 DE 60212861 T DE60212861 T DE 60212861T DE 60212861 T DE60212861 T DE 60212861T DE 60212861 D1 DE60212861 D1 DE 60212861D1
Authority
DE
Germany
Prior art keywords
obesity
diagnosis
polymorphisms
therapy
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60212861T
Other languages
English (en)
Other versions
DE60212861T2 (de
Inventor
Philippe Boutin
Severine Dubois
Christian Dina
Philippe Froguel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60212861D1 publication Critical patent/DE60212861D1/de
Application granted granted Critical
Publication of DE60212861T2 publication Critical patent/DE60212861T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60212861T 2002-12-13 2002-12-13 Verfahren zur Diagnose von Fettsucht Expired - Lifetime DE60212861T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02293085A EP1428875B1 (de) 2002-12-13 2002-12-13 Verfahren zur Diagnose von Fettsucht

Publications (2)

Publication Number Publication Date
DE60212861D1 true DE60212861D1 (de) 2006-08-10
DE60212861T2 DE60212861T2 (de) 2007-03-01

Family

ID=32319694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212861T Expired - Lifetime DE60212861T2 (de) 2002-12-13 2002-12-13 Verfahren zur Diagnose von Fettsucht

Country Status (9)

Country Link
US (1) US20060269919A1 (de)
EP (2) EP1428875B1 (de)
JP (1) JP2006509519A (de)
AT (1) ATE331784T1 (de)
AU (1) AU2003276616A1 (de)
CA (1) CA2509831A1 (de)
DE (1) DE60212861T2 (de)
ES (1) ES2266432T3 (de)
WO (1) WO2004055180A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087789A1 (de) 2008-02-06 2009-08-12 Heinrich-Heine-Universität Düsseldorf FTO-modifiziertes nichtmenschliches Säugetier
JP5677291B2 (ja) 2009-05-15 2015-02-25 国立大学法人 東京大学 肥満素因の評価方法及びキット、並びに、抗肥満薬及びそのスクリーニング方法、非ヒト動物、脂肪組織、脂肪細胞、トランスジェニックマウス作成方法、抗原、抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512976A (ja) * 1997-02-25 2001-08-28 ジェンザイム・トランスジェニックス・コーポレーション トランスジェニックにより産生された非分泌性タンパク質
WO2000025798A1 (en) * 1998-11-05 2000-05-11 Thomas Jefferson University Treatment of parkinson's disease with oligonucleotides
JP4219617B2 (ja) * 2001-06-15 2009-02-04 独立行政法人科学技術振興機構 グリーン蛍光タンパク質遺伝子により形質転換されたトランスジェニック動物

Also Published As

Publication number Publication date
US20060269919A1 (en) 2006-11-30
WO2004055180A1 (en) 2004-07-01
ES2266432T3 (es) 2007-03-01
EP1572999A1 (de) 2005-09-14
EP1428875B1 (de) 2006-06-28
AU2003276616A1 (en) 2004-07-09
JP2006509519A (ja) 2006-03-23
CA2509831A1 (en) 2004-07-01
DE60212861T2 (de) 2007-03-01
EP1428875A1 (de) 2004-06-16
ATE331784T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
DE60035163D1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
IN2015KN00290A (de)
ATE474847T1 (de) Verfahren zur herstellung von dipeptiden
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
BRPI0407207A (pt) Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter
WO2003007803A3 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
WO2004043232A3 (en) Methods for identifying risk of melanoma and treatments thereof
DE60331111D1 (de) Verfahren zur Herstellung von martensitaushärtendem Stahl
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60209541D1 (de) Verfahren zur herstellung von sekundären und tertiären aminofunktionellensilanen, iminoorganosilanen und/oder imidoorganosilanen
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
ATE400560T1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
ATE402684T1 (de) Elastische befestigungslasche, befestigungssystem und verfahren zur herstellung davon
GB0228337D0 (en) Replication protein
DE60212861D1 (de) Verfahren zur Diagnose von Fettsucht
DE60324272D1 (de) Verfahren zum kühlen von stahlblech und verfahren zur herstellung von stahlblech
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
EP1566386A4 (de) Gen in zusammenhang mit haarausfall, das davon kodierte polypeptid und anwendungen dafür
DE602004030107D1 (de) Suszeptibilitätsgen für die alzheimersche krankheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition